Matches in Wikidata for { <http://www.wikidata.org/entity/Q97676809> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- Q97676809 description "article scientifique publié en 2020" @default.
- Q97676809 description "artículu científicu espublizáu en xunetu de 2020" @default.
- Q97676809 description "im Juli 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q97676809 description "scientific article published on 23 July 2020" @default.
- Q97676809 description "wetenschappelijk artikel" @default.
- Q97676809 description "наукова стаття, опублікована 23 липня 2020" @default.
- Q97676809 name "A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Regorafenib vs. Placebo in Advanced/Metastatic, Treatment-Refractory Liposarcoma: Results from the SARC024 Study" @default.
- Q97676809 name "A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Regorafenib vs. Placebo in Advanced/Metastatic, Treatment-Refractory Liposarcoma: Results from the SARC024 Study" @default.
- Q97676809 type Item @default.
- Q97676809 label "A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Regorafenib vs. Placebo in Advanced/Metastatic, Treatment-Refractory Liposarcoma: Results from the SARC024 Study" @default.
- Q97676809 label "A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Regorafenib vs. Placebo in Advanced/Metastatic, Treatment-Refractory Liposarcoma: Results from the SARC024 Study" @default.
- Q97676809 prefLabel "A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Regorafenib vs. Placebo in Advanced/Metastatic, Treatment-Refractory Liposarcoma: Results from the SARC024 Study" @default.
- Q97676809 prefLabel "A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Regorafenib vs. Placebo in Advanced/Metastatic, Treatment-Refractory Liposarcoma: Results from the SARC024 Study" @default.
- Q97676809 P1433 Q97676809-B91A1A3B-14CF-40B4-9508-9B32C0AA20AC @default.
- Q97676809 P1476 Q97676809-7AE10699-C8D5-4B28-9FF7-5E7A82376E51 @default.
- Q97676809 P2093 Q97676809-0347B178-519C-4267-BDB3-473F0F3B6B5A @default.
- Q97676809 P2093 Q97676809-04513BF9-BE8B-41DC-B197-30FA98B5B6BA @default.
- Q97676809 P2093 Q97676809-0E1E9925-D1DA-4B4D-A74A-3419C478D435 @default.
- Q97676809 P2093 Q97676809-173A792B-642F-4862-A454-1BF31D8F0A6B @default.
- Q97676809 P2093 Q97676809-21D6308D-7C5F-4C59-BACC-9967AACA3FFE @default.
- Q97676809 P2093 Q97676809-3B899A29-4BEF-4C88-9CBF-8B5F66D00C48 @default.
- Q97676809 P2093 Q97676809-584CF191-ED9C-4C30-ACAD-7B83BF4E2406 @default.
- Q97676809 P2093 Q97676809-7D7ED148-109B-4513-AB28-09D23C2B7F3F @default.
- Q97676809 P2093 Q97676809-8D7F96E3-553E-4946-854A-273C0217F96E @default.
- Q97676809 P2093 Q97676809-95603632-EF00-4D89-8ABD-087F666F64E1 @default.
- Q97676809 P2093 Q97676809-98209AA8-9FDF-4105-8670-3812AF9B5015 @default.
- Q97676809 P2093 Q97676809-B154C5DD-941D-44FA-B75D-EC703445E7D6 @default.
- Q97676809 P2093 Q97676809-B9BBBAB4-0309-4EC0-9109-F2F4F87615B1 @default.
- Q97676809 P2093 Q97676809-CBC794A1-7636-4341-9A1C-CEC0167FFFE7 @default.
- Q97676809 P2093 Q97676809-D19FF9DB-D887-4BD7-8905-0CD08BD2F224 @default.
- Q97676809 P2093 Q97676809-D70CD852-88A8-4667-A60F-4B1B5B08C5D2 @default.
- Q97676809 P2093 Q97676809-F5B9132E-BA8A-4B63-896C-FA7DFBFFD232 @default.
- Q97676809 P2093 Q97676809-FFC68B7F-BEBD-4235-84EE-452654DA6776 @default.
- Q97676809 P275 Q97676809-e8ed9408-c44a-400c-af46-3cc2b84ee364 @default.
- Q97676809 P31 Q97676809-AF43359A-2128-409F-BE6A-6F91F1A204BF @default.
- Q97676809 P356 Q97676809-61B2A779-E036-465F-AEEE-8AE085B8713C @default.
- Q97676809 P50 Q97676809-1638418C-66B3-4D7C-84D6-71CF2ADB45B5 @default.
- Q97676809 P577 Q97676809-1D0C0214-8DF8-4B17-A67D-DE4EE6B2C46B @default.
- Q97676809 P6216 Q97676809-54720b43-7e01-413d-b0e6-b8f11ad9bac7 @default.
- Q97676809 P698 Q97676809-0B527DF0-D086-4619-BC53-5A800D716349 @default.
- Q97676809 P932 Q97676809-17251BDB-E8E5-452F-A163-1EDEBF41C3D0 @default.
- Q97676809 P356 THEONCOLOGIST.2020-0679 @default.
- Q97676809 P698 32701199 @default.
- Q97676809 P1433 Q2122327 @default.
- Q97676809 P1476 "A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Regorafenib vs. Placebo in Advanced/Metastatic, Treatment-Refractory Liposarcoma: Results from the SARC024 Study" @default.
- Q97676809 P2093 "Christopher Ryan" @default.
- Q97676809 P2093 "Damon R Reed" @default.
- Q97676809 P2093 "Daniel Rushing" @default.
- Q97676809 P2093 "David A Liebner" @default.
- Q97676809 P2093 "Denise K Reinke" @default.
- Q97676809 P2093 "Elizabeth T Loggers" @default.
- Q97676809 P2093 "Jennifer Wright" @default.
- Q97676809 P2093 "John H Ward" @default.
- Q97676809 P2093 "Karla V Ballman" @default.
- Q97676809 P2093 "Kristen N Ganjoo" @default.
- Q97676809 P2093 "Lara E Davis" @default.
- Q97676809 P2093 "Leo Mascarenhas" @default.
- Q97676809 P2093 "Michael B Livingston" @default.
- Q97676809 P2093 "Robert G Maki" @default.
- Q97676809 P2093 "Scott H Okuno" @default.
- Q97676809 P2093 "Steven Attia" @default.
- Q97676809 P2093 "Vicki L Keedy" @default.
- Q97676809 P2093 "Warren Chow" @default.
- Q97676809 P275 Q24082749 @default.
- Q97676809 P31 Q13442814 @default.
- Q97676809 P356 "10.1634/THEONCOLOGIST.2020-0679" @default.
- Q97676809 P50 Q92405926 @default.
- Q97676809 P577 "2020-07-23T00:00:00Z" @default.
- Q97676809 P6216 Q50423863 @default.
- Q97676809 P698 "32701199" @default.
- Q97676809 P932 "7648334" @default.